These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9085331)

  • 1. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
    Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
    Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES; Baim DS; Smith HS; Lanoue AS; Silverman KJ; Gervino EV; Grossman W
    Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
    Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
    Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
    Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
    Baruch L; Patacsil P; Hameed A; Pina I; Loh E
    Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone].
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
    Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.